A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.

Solvay Pharmaceuticals148 enrolled

Overview

To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

148

Conditions

Obesity

Interventions

Metformin and Metformin + FenofibrateDRUG

Eligibility

Sex: ALLMin age: 30 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Both genders, BMI ≥ 30 kg/m² and \<40 kg/m². Exclusion Criteria: * Known abnormal thyroid hormone levels, or high thyroid stimulating hormone (TSH) level.

Locations (3)

Site 1

Helsinki, Finland

Site 3

Kuopio, Finland

Site 2

Oulu, Finland

Outcomes

Primary Outcomes

Weight

Secondary Outcomes

Waist and hip circumference

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.